| AGM 30/09/2011
Parenteral Drugs India Ltd has informed BSE that 27th Annual General Meeting (AGM) of the Company was held on September 30, 2011 inter alia, have accorded to the following:
- Ordinary Business:
1. Adoption of the Balance Sheet of the Company as at March 31, 2011, the profit and loss account, all annexures thereto and the Cash Flow Statement for the year ended on that date and the report of the Director`s and Auditors` thereon.
2. Re-appointment of Mr. Govind Das Garg & Mr. Dilip Kumar Sinha as an Ordinary Directors of the Company.
3. Appointment of M/s. T. N. Unni & Co., Chartered Accountants, Indore, as statutory auditors of the Company, from the conclusion of this annual general meeting till the conclusion of next annual general meeting of the Company on remuneration, terms & conditions.
- Special Business:
4. Authority to the Board to create such mortgages and charges in addition to the existing mortgages and charges already created or to be created by the Company, as the Board may decided, on the assets of the Company, whether movable or immovable, both present and future, in favour of State Bank of India and Punjab National Bank, the Bankers of the Company to secure various financial facilities extended by them to the Company to the tune of Rs. 353.50 crores (Rupees three hundred fifty three crores and fifty lacs).
5. Re-appointment of Mr. Govind Das Garg as Whole-time Director of the Company for a further period of three years w.e.f. January 01, 2012, on remuneration, terms & conditions.
6. Re-appointment of Mr. Aditya Gupta, as "Project Coordinator" of the Company for a further period of five years w.e.f. April 01, 2012, on remuneration, terms & conditions.
7. Re-appointment of Mr. Ashish Garg, as "Purchase Coordinator" of the Company for a period of five years w.e.f. April 01, 2011, on remuneration, terms & conditions.
(As Per BSE Announcement Dated on 11.10.2011) |
| Parenteral Drugs (India) Limited has informed the Exchange that the Annual General Meeting of the Company will be held on September 30, 2010.
Parenteral Drugs India Ltd has informed BSE that the members at the 26th Annual General Meeting (AGM) of the Company held on September 30, 2010. inter alia, have accorded to the following :
1. Adoption of the Balance Sheet of the Company as at March 31, 2010, the profit and loss account, all annexures thereto and the Cash Flow Statement for the year ended on that date and the report of the Directors` and Auditors` thereon with the report on Corporate Governance and the consolidated financial accounts of the Company with that of its subsidiary Companies.
2. Declaration of Dividend of 20% (i.e. Rs.2.00 per share) on the fully paid up equity shares of Rs. 10/- each of the Company for the financial year 2009-2010 to the eligible equity shareholders of the Company.
3. Re-appointment of Mr. Dharam Pal Khanna, as Director of the Company.
4. Appointment of Mr. Anil Mittal, as Director of the Company."
5. Appointment of M/s. T. N. Unni & Co., Chartered Accountants, Indore, as statutory auditors of the Company, from the conclusion of this annual general meeting till the conclusion of next annual general meeting of the Company on such remuneration as may be decided by the audit committee in consultation with the auditors of the Company.
6. Authority to Board to create such mortgages and charges in addition to the existing mortgages and charges already created or to be created by the Company, as the Board may decide, on the assets of the Company, whether movable or immovable, both present and future, in favour of State Bank of India and Punjab National Bank, the Bankers of the Company to secure various financial facilities extended by them to the Company to the tune of Rs. 349.00 crores (Rupees three hundred and forty nine crores).
7. Approval of the members of the Company is accorded to issue and allot 59,26,400 (Fifty nine lacs twenty six thousand and four hundred) 0% Non-Convertible, Redeemable Preference Shares of Rs. 10/- (Rupees Ten) each, to such promoters of the Company as the Board of Directors may consider fit, without issuing such preference shares to the existing shareholders of the Company, in terms of provisions of section 81 of the Companies Act, 1956;
8. Re-appointment of Mr. Anil Mittal as Whole-Time Director of the Company for a further period of 5 (five) years w.e.f. January 30, 2011, on a consolidated monthly remuneration of Rs. 2,00,000/- payment of bonus and other perquisites as per the Company rules, contribution to Provident and Gratuity Fund as may be applicable.
9. To increase the Authorised Share Capital of the Company from Rs. 40,00,00,000/- (Rupees Forty Crores) divided into 2,65,00,000 (Two Crores Sixty Five Lacs) Equity Shares of Rs. 10/- each, 35,00,000 (Thirty Five Lacs) 0% Non-Cumulative, Non-Convertible, Redeemable Preference Shares of Rs. 10/- each, 29,62,102 (Twenty Nine Lacs Sixty Two Thousand One Hundred Two) 0% Optionally Convertible Redeemable Preference Shares of Rs. 10/- each and 70,37,898 (Seventy Lacs Thirty Seven Thousand Eight Hundred Ninety Eight) 0% Non-Convertible, Redeemable Preference Shares of Rs. 10/-each aggregating to Rs. 40,00,00,00/- (Rupees Forty Crores) to Rs. 50,00,00,000/- (Rupees Fifty Crores) divided into 3,65,00,000 (Three Crores Sixty Five Lacs) Equity Shares of Rs. 10/-each, 35,00,000 (Thirty Five Lacs) 0% Non-Cumulative, Non-Convertible, Redeemable Preference Shares of Rs. 10/-each, 29,62,102 (Twenty Nine Lacs Sixty Two Thousand One Hundred Two) 0% Optionally Convertible Redeemable Preference Shares of Rs. 10/-each and 70,37,898 (Seventy Lacs Thirty Seven Thousand Eight Hundred Ninety Eight) 0% Non-Convertible, Redeemable Preference Shares of Rs. 10/-each aggregating to Rs. 50,00,00,000/- (Rupees Fifty Crores) and consequential amendments in the Memorandum of Association of the Company.
(As Per BSE Annoucement Website dated on 14.10.2010) |